Skip to Main Content
TABLE 2

Changes in screened analytes over the 4-week study period

Control group
Treatment group
P
Initial valueChange in value at 4 weeksInitial valueChange in value at 4 weeks
n 12 12 14 14 — 
Leptin (ng/ml) 283 ± 24 31 ± 25 325 ± 50 −79 ± 35 0.0185* 
Adiponectin (μg/ml) 111.4 ± 11.3 −7.6 ± 3.0 83.6 ± 9.5 8.3 ± 4.3 0.0068* 
Insulin (pmol/l) 26.7 ± 8.5 −1.1 ± 5.4 34.5 ± 4.7 −7.8 ± 4.4 0.3394 
Glucose (mmol/l) 4.61 ± 0.09 0.21 ± 0.09 4.76 ± 0.11 0.12 ± 0.08 0.4111 
Cholesterol (mmol/l) 4.71 ± 0.26 −0.26 ± 0.15 4.66 ± 0.19 −0.15 ± 0.11 0.5154 
HDL (mmol/l) 1.07 ± 0.06 −0.01 ± 0.03 1.12 ± 0.09 −0.02 ± 0.03 0.8459 
Ghrelin (pmol/l 493 ± 87 47 ± 58 371 ± 65 35 ± 44 0.8586 
Peptide YY (pmol/l) 11.8 ± 1.6 −2.6 ± 1.5 12.2 ± 2.1 −0.6 ± 1.6 0.3651 
Control group
Treatment group
P
Initial valueChange in value at 4 weeksInitial valueChange in value at 4 weeks
n 12 12 14 14 — 
Leptin (ng/ml) 283 ± 24 31 ± 25 325 ± 50 −79 ± 35 0.0185* 
Adiponectin (μg/ml) 111.4 ± 11.3 −7.6 ± 3.0 83.6 ± 9.5 8.3 ± 4.3 0.0068* 
Insulin (pmol/l) 26.7 ± 8.5 −1.1 ± 5.4 34.5 ± 4.7 −7.8 ± 4.4 0.3394 
Glucose (mmol/l) 4.61 ± 0.09 0.21 ± 0.09 4.76 ± 0.11 0.12 ± 0.08 0.4111 
Cholesterol (mmol/l) 4.71 ± 0.26 −0.26 ± 0.15 4.66 ± 0.19 −0.15 ± 0.11 0.5154 
HDL (mmol/l) 1.07 ± 0.06 −0.01 ± 0.03 1.12 ± 0.09 −0.02 ± 0.03 0.8459 
Ghrelin (pmol/l 493 ± 87 47 ± 58 371 ± 65 35 ± 44 0.8586 
Peptide YY (pmol/l) 11.8 ± 1.6 −2.6 ± 1.5 12.2 ± 2.1 −0.6 ± 1.6 0.3651 

Data are means ± SE. An unpaired t test was used to compare changes in the control vs. the treatment group.

*

Significant difference.

Close Modal

or Create an Account

Close Modal
Close Modal